243 related articles for article (PubMed ID: 35996808)
1. Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction.
Liu X; Chen W; Shao W; Jiang Y; Cao Z; He W; Wu M; Chen Z; Ma J; Chen Y; Yu P; Zhang Y; Wang J
ESC Heart Fail; 2022 Dec; 9(6):3985-3994. PubMed ID: 35996808
[TBL] [Abstract][Full Text] [Related]
2. Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction.
Cao Y; Guo S; Dong Y; Liu C; Zhu W
ESC Heart Fail; 2023 Jun; 10(3):1771-1780. PubMed ID: 36864701
[TBL] [Abstract][Full Text] [Related]
3. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT.
Peters AE; Pandey A; Ayers C; Wegermann K; McGarrah RW; Grodin JL; Abdelmalek MF; Bekfani T; Blumer V; Diehl AM; Moylan CA; Fudim M
ESC Heart Fail; 2021 Apr; 8(2):842-848. PubMed ID: 33586354
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C
ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643
[TBL] [Abstract][Full Text] [Related]
5. Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients.
Wang Z; Wang Y; Luo F; Zhai Y; Li J; Chen Y; Li Q; Zhu L; Jiao S; Liu P; Zhou Y; Chen Y; Dong J; Sun Y
Front Cardiovasc Med; 2022; 9():960259. PubMed ID: 36277780
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction.
O'Neal WT; Sandesara P; Patel N; Venkatesh S; Samman-Tahhan A; Hammadah M; Kelli HM; Soliman EZ
Eur Heart J Cardiovasc Imaging; 2017 Jul; 18(7):725-729. PubMed ID: 28379310
[TBL] [Abstract][Full Text] [Related]
7. FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.
So-Armah KA; Lim JK; Lo Re V; Tate JP; Chang CH; Butt AA; Gibert CL; Rimland D; Marconi VC; Goetz MB; Ramachandran V; Brittain E; Long M; Nguyen KL; Rodriguez-Barradas MC; Budoff MJ; Tindle HA; Samet JH; Justice AC; Freiberg MS;
Prog Cardiovasc Dis; 2020; 63(2):184-191. PubMed ID: 32068085
[TBL] [Abstract][Full Text] [Related]
8. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
Europace; 2023 May; 25(5):. PubMed ID: 37078691
[TBL] [Abstract][Full Text] [Related]
9. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
Hydes TJ; Kennedy OJ; Buchanan R; Cuthbertson DJ; Parkes J; Fraser SDS; Roderick P
BMC Med; 2023 May; 21(1):185. PubMed ID: 37198624
[TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta-analysis.
Yan Z; Liu Y; Li W; Zhao X; Lin W; Zhang J; Yu S; Ma J; Wang J; Yu P; Li W; Liu X
Eur J Clin Invest; 2022 Nov; 52(11):e13855. PubMed ID: 36001034
[TBL] [Abstract][Full Text] [Related]
11. Advanced liver fibrosis and the metabolic syndrome in a primary care setting.
Schreiner AD; Zhang J; Durkalski-Mauldin V; Livingston S; Marsden J; Bian J; Mauldin PD; Moran WP; Rockey DC
Diabetes Metab Res Rev; 2021 Nov; 37(8):e3452. PubMed ID: 33759300
[TBL] [Abstract][Full Text] [Related]
12. Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Kang MK; Park JG; Kim MC
Yonsei Med J; 2020 Oct; 61(10):860-867. PubMed ID: 32975060
[TBL] [Abstract][Full Text] [Related]
13. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease.
Huang C; Seah JJ; Tan CK; Kam JW; Tan J; Teo EK; Kwek A; Wong YJ; Tan M; Ang TL; Kumar R
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101528. PubMed ID: 33268036
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
Nicoli CD; O'Neal WT; Levitan EB; Singleton MJ; Judd SE; Howard G; Safford MM; Soliman EZ
Heart; 2022 Mar; 108(5):353-359. PubMed ID: 34031160
[TBL] [Abstract][Full Text] [Related]
15. Amplified P-wave duration predicts new-onset atrial fibrillation in patients with heart failure with preserved ejection fraction.
Müller-Edenborn B; Minners J; Kocher S; Chen J; Zeh W; Lehrmann H; Allgeier J; Neumann FJ; Arentz T; Jadidi A
Clin Res Cardiol; 2020 Aug; 109(8):978-987. PubMed ID: 31863175
[TBL] [Abstract][Full Text] [Related]
16. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.
Cikes M; Claggett B; Shah AM; Desai AS; Lewis EF; Shah SJ; Anand IS; O'Meara E; Rouleau JL; Sweitzer NK; Fang JC; Saksena S; Pitt B; Pfeffer MA; Solomon SD
JACC Heart Fail; 2018 Aug; 6(8):689-697. PubMed ID: 30007557
[TBL] [Abstract][Full Text] [Related]
17. Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.
Yoshihisa A; Sato Y; Yokokawa T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Saitoh SI; Takeishi Y
ESC Heart Fail; 2018 Apr; 5(2):262-270. PubMed ID: 28967709
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study.
Baratta F; Pastori D; Angelico F; Balla A; Paganini AM; Cocomello N; Ferro D; Violi F; Sanyal AJ; Del Ben M
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2324-2331.e4. PubMed ID: 31887443
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients.
Sun Y; Hong L; Huang Z; Wang L; Xiong Y; Zong S; Zhang R; Liu J; Zang S
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3661-e3669. PubMed ID: 35766414
[TBL] [Abstract][Full Text] [Related]
20. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
O'Neal WT; Sandesara P; Hammadah M; Venkatesh S; Samman-Tahhan A; Kelli HM; Soliman EZ
Am J Cardiol; 2017 Jun; 119(11):1785-1790. PubMed ID: 28395886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
